A couple of weeks ago, we blogged about the strides being made to combat melanomas by releasing the brakes on the immune system. Last week, the FDA approved Bristol-Myers Squibb's Opdivo (nivolumab), an immunotherapy drug that has had dramatic results in lengthening the lives of patients with some late-stage melanomas.
Read MoreTags: cancer, clinical trials, immunotherapy, drugs
On Sunday, the Wall Street Journal published a business story (login required for the full story) about a new approach to treating cancer, and particularly a few late stage cancers. According to the story, investors like Michael Milken, George Soros, Jeff Bezos and Paul Allen are among best-known names betting on an emerging sector of cancer drug development called immunotherapy.
Read MoreTags: cancer, Innovations, drug development, immunotherapy
Download the ebook based on our popular blog series. This free, 50+ page edition features updated, expanded posts and redesigned, easier-to-read maps.
Learn about the applications, opportunities and challenges in this updated free white paper.